关于参加 2022 年度半导体专场集体业绩说明会 暨现金分红说明会的公告 证券代码：688199 证券简称：久日新材 公告编号：2023-023 天津久日新材料股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 会议线上交流时间：2023 年 5 月 17 日（星期三）下午 14:00-16:00 会议召开方式：视频和线上文字互动 视 频 和 线 上 文 字 互 动 平 台 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （http://roadshow.sseinfo.com/） 投资者可于 2023 年 5 月 16 日（星期二）16:00 前通过邮件、电话等形 式将需要了解和关注的问题提前提供给公司。公司将在文字互动环节对投资者普 遍关注的问题进行回答。 天津久日新材料股份有限公司（以下简称公司）已于 2023 年 4 月 15 日发布 公司《2022 年年度报告》，为便于广大投资者更全面深入地了解公司 2022 年度 经营成果、财务状况、发展理念及现金分红的具体情况，公司参与了由上 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥265,902,365.16, representing a decrease of 37.14% compared to the same period last year[4] - The net profit attributable to shareholders was a loss of ¥17,849,017.84, a decline of 132.59% year-over-year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was a loss of ¥24,293,284.17, reflecting a decrease of 151.03% compared to the previous year[4] - The net cash flow from operating activities was negative at ¥40,395,654.20, a decline of 207.85% year-over-year[4] - The company attributed the decline in revenue and profit to external market conditions and a decrease in sales prices of photoinitiators, despite a slight increase in sales volume[8] - Net profit for Q1 2023 was a loss of ¥20,798,143.39, compared to a profit of ¥60,206,842.13 in Q1 2022[18] - The company reported a gross profit margin of -5.4% in Q1 2023, compared to 14.0% in Q1 2022[17] - Operating profit for Q1 2023 was a loss of ¥12,368,402.33, compared to a loss of ¥473,781.76 in Q1 2022[30] - Net profit for Q1 2023 was a loss of ¥12,963,550.35, compared to a loss of ¥1,003,382.62 in Q1 2022, indicating a worsening financial performance[30] Research and Development - The total R&D investment amounted to ¥14,621,941.34, which is a decrease of 31.06% compared to the previous year[4] - R&D investment accounted for 5.50% of operating revenue, an increase of 0.49 percentage points year-over-year[5] - Research and development expenses for Q1 2023 were ¥14,621,941.34, a decrease of 30.8% from ¥21,208,575.74 in Q1 2022[17] - Research and development expenses decreased to ¥3,553,060.76 in Q1 2023 from ¥5,092,449.04 in Q1 2022, reflecting a 30.3% reduction[28] Assets and Liabilities - Total assets at the end of the reporting period were ¥4,063,682,545.30, a decrease of 1.03% from the end of the previous year[5] - The company's total assets amounted to CNY 4,063,682,545.30, a decrease from CNY 4,105,789,706.50 at the end of 2022, reflecting a decline of approximately 1.02%[13] - The total current assets decreased to CNY 1,825,154,911.49 from CNY 1,896,250,492.13, indicating a reduction of approximately 3.73%[14] - The company's total liabilities increased to CNY 1,800,000,000.00, reflecting a rise in financial obligations[14] - The company's total liabilities decreased to ¥1,255,835,304.83 in Q1 2023 from ¥1,279,229,157.38 in Q1 2022[16] - Total liabilities reached CNY 1.28 billion, with current liabilities at CNY 930.55 million and non-current liabilities at CNY 348.68 million[38] - The company's total liabilities increased to 472,416,697.09 RMB from 446,077,648.21 RMB, indicating a rise in financial obligations[26] Cash Flow - The net cash flow from operating activities was -40,395,654.20 RMB, a significant decline compared to 37,454,291.96 RMB in the previous year, indicating a negative cash flow trend[22] - Cash flow from operating activities was ¥224,371,631.59 in Q1 2023, down 39.0% from ¥367,953,548.42 in Q1 2022[21] - The net cash flow from financing activities was 73,535,817.62 RMB, down from 148,878,918.15 RMB in the previous year, suggesting a decrease in financing efficiency[23] - The cash flow from investment activities showed a net increase of 60,626,737.18 RMB, a significant improvement from a net outflow of -244,329,279.32 RMB in the previous year[22] - The company achieved cash inflow from investment activities of ¥760,122,843.38 in Q1 2023, compared to ¥284,208,949.98 in Q1 2022[32] Shareholder Information - The number of shares held by the top shareholder, Zhao Guofeng, is 19,771,609, representing 17.78% of the total shares[12] - The company has a share repurchase account holding 2,821,248 shares, accounting for 2.54% of the total share capital[12] - The total equity attributable to shareholders was ¥2,706,190,529.17 in Q1 2023, slightly down from ¥2,722,303,782.74 in Q1 2022[16] - Shareholders' equity totaled CNY 2.83 billion, with retained earnings of CNY 599.70 million[39] Inventory and Current Assets - Inventory levels decreased to CNY 328,494,119.38 from CNY 376,395,490.72, showing a decline of about 12.74%[14] - The company's receivables from accounts increased to CNY 206,480,187.18 from CNY 188,958,277.39, marking a rise of about 9.43%[13] - The company's total current assets were 1,681,516,241.08 RMB, slightly up from 1,672,370,769.20 RMB year-over-year, indicating stable asset management[24] Financial Ratios and Metrics - The weighted average return on net assets was -0.66%, a decrease of 2.64 percentage points compared to the previous year[4] - Basic and diluted earnings per share for Q1 2023 were both -¥0.16, compared to ¥0.51 in Q1 2022[19] - The company reported an investment loss of ¥419,077.07 in Q1 2023, compared to a profit of ¥8,523,345.98 in Q1 2022[18] - The company's financial expenses showed a significant improvement, with a net financial expense of -¥103,604.00 in Q1 2023 compared to ¥1,809,197.88 in Q1 2022[28]

Financial Performance - In 2022, the company achieved operating revenue of CNY 1,410,958,551.74, an increase of 12.66% year-on-year[4] - The net profit attributable to shareholders was CNY 43,347,271.78, a decrease of 73.83% year-on-year[4] - The company's operating revenue for 2022 was approximately ¥1.41 billion, representing a 12.66% increase compared to ¥1.25 billion in 2021[29] - The net profit attributable to shareholders decreased by 73.83% to approximately ¥43.35 million from ¥165.66 million in 2021[29] - The basic earnings per share dropped by 73.86% to ¥0.40 from ¥1.53 in the previous year[30] - The net cash flow from operating activities increased by 97.21% to approximately ¥144.06 million, driven by higher cash receipts from sales and increased tax refunds[31] - The total assets at the end of 2022 were approximately ¥4.11 billion, a 6.29% increase from ¥3.86 billion at the end of 2021[29] - The weighted average return on equity decreased to 1.59% from 6.24% in 2021, indicating a significant decline in profitability[30] - The net profit attributable to shareholders after deducting non-recurring gains and losses fell by 87.14% to approximately ¥16.22 million from ¥126.17 million in 2021[29] - The company's gross profit margin decreased by 9.03 percentage points, with a gross profit margin of 18.52%[123] Production and Capacity Expansion - The company expanded its production capacity with the launch of a project in Inner Mongolia, targeting an annual output of 9,250 tons of photoinitiators and intermediates[5] - The company initiated a project for a microelectronics photoinitiator with an annual capacity of 600 tons, which began trial production in October 2022[6] - The company has established multiple production bases to ensure stable supply and customer demand for key photoinitiator products, including 184, TPO, and 1173[51] - The company is investing in new production lines to increase the value of its products, such as the feed-grade benzoic acid production line[165] - The company has built modern production bases in Shandong, Jiangsu, Hunan, and Inner Mongolia, enhancing its supply stability and capacity[96] Research and Development - The company added 52 new authorized patents during the reporting period, including 25 invention patents and 27 utility model patents, enhancing its innovation capabilities[42] - Research and development investments increased by 40%, totaling RMB 100 million, focusing on advanced photoinitiators[21] - The total R&D investment for the year was approximately ¥84.52 million, representing a 19.45% increase from the previous year's ¥70.76 million[79] - R&D investment accounted for 5.99% of total revenue, an increase of 0.34 percentage points compared to the previous year[79] - The company has established a strong R&D foundation with 136 patents, including 89 invention patents[91] - The company is focusing on sustainable development through the improvement of waste treatment processes in its production operations[75] Market Strategy and Challenges - The company aims to maintain its market share by implementing sales strategies, including price reductions, despite the impact on revenue and profit margins[11] - The company has faced challenges due to a significant decline in market demand, leading to a reduction in sales volume of photoinitiators compared to the previous year[11] - The company is actively expanding its market presence and enhancing its competitive advantage through strategic acquisitions and new product development[96] - The company is facing risks of continued performance decline if external market conditions do not improve, despite a gradual recovery in the industry[101] - The company is exposed to foreign exchange risks, particularly with fluctuations in the RMB to USD exchange rate affecting export revenues[106] Environmental and Regulatory Factors - The demand for UV-curable products is expected to increase due to stricter environmental regulations and consumer preferences for safer products[57] - The company is well-positioned to benefit from favorable policies related to energy conservation and emissions reduction in the context of the national "dual carbon" goals[150] - The company has implemented innovative production processes that significantly reduce raw material consumption and waste generation, achieving near-zero wastewater production[155] Acquisitions and Investments - The company acquired 100% equity of Huaihua Taitong, which produces key raw materials for its core photoinitiator products, ensuring stable supply[44] - The company made significant acquisitions, including Hunan Jiuri's purchase of Hongrun Chemical and Huaihua Taitong, contributing to revenue growth[120] - The company plans to invest an additional 31,332.02 million RMB in the Inner Mongolia Jiuri project, increasing the total investment from 55,045.70 million RMB to 86,377.72 million RMB[181] Product Development and Innovation - The company is focused on continuous product development and expanding application areas to drive future growth[56] - The company has developed new core technologies including "photo-sensitizer production technology" and "panel photoresist formulation technology" during the reporting period[69] - The company has successfully developed new photoinitiators tailored for specific applications, enhancing its product offerings[156] Financial Management and Performance Metrics - The company has implemented measures to mitigate production stoppages due to environmental and safety regulations, but risks remain from external factors[111] - The company has experienced a significant decrease in financial expenses by 71.90%, mainly due to exchange rate fluctuations[137] - The company's cash flow from financing activities was CNY 153,278,949.19, compared to a negative cash flow of CNY -50,343,272.44 in the previous year, indicating a significant improvement[138]

Financial Performance - The company reported a significant increase in revenue, achieving a total of 500 million RMB for the first half of 2022, representing a 20% year-over-year growth[13]. - The company's operating revenue for the first half of 2022 was approximately ¥817.45 million, an increase of 30.02% compared to ¥628.70 million in the same period last year[20]. - The net profit attributable to shareholders for the first half of 2022 was approximately ¥99.88 million, representing a 19.38% increase from ¥83.66 million in the previous year[20]. - The basic earnings per share for the first half of 2022 was ¥0.92, up 19.48% from ¥0.77 in the same period last year[19]. - The net cash flow from operating activities increased by 88.56% to approximately ¥130.72 million, compared to ¥69.33 million in the previous year[20]. - The net profit attributable to shareholders after deducting non-recurring gains and losses increased by 47.03% to approximately ¥83.67 million, compared to ¥56.91 million in the same period last year[20]. - The company's total assets as of the end of the reporting period were approximately ¥4.40 billion, a 13.80% increase from ¥3.86 billion at the end of the previous year[20]. - The company has maintained a strong cash position, with cash reserves amounting to 200 million RMB, ensuring liquidity for future investments[13]. Research and Development - The company is investing 30 million RMB in R&D for new technologies aimed at improving production efficiency by 15%[13]. - The company's R&D investment accounted for 5.59% of operating revenue, an increase of 0.22 percentage points from the previous year[19]. - The company achieved a total R&D investment of ¥45,659,094.27, representing a 35.16% increase compared to ¥33,780,917.25 in the same period last year[58]. - The company added 39 new authorized patents during the reporting period, including 15 invention patents and 24 utility model patents, enhancing its innovation capabilities[76]. - The company holds 123 patents, including 79 invention patents and 44 utility model patents, and has participated in the formulation of 9 industry standards[67]. - The company has a strong focus on R&D, holding 79 invention patents and 44 utility model patents, enhancing its innovation capabilities[32]. - The company is actively exploring new product developments, including high-performance UV monomers and low-odor photoinitiators, to cater to diverse customer needs[34]. Market Expansion and Strategy - The company is expanding its market presence, targeting new regions in Southeast Asia, with an investment of 50 million RMB allocated for market entry strategies[13]. - A strategic acquisition of a local competitor is in progress, which is projected to enhance market share by 10%[13]. - The company has acquired subsidiaries Hunan Jiuri and Hongrun Chemical, contributing to the increase in consolidated revenue[20]. - The company is adapting to market demands by developing customized photoinitiators that meet the specific needs of downstream customers[41]. - The company is focusing on the development of UV LED photoinitiators suitable for light-colored inks and wood coatings, which are characterized by excellent performance and cost-effectiveness[53]. - The company is expanding its market presence through strategic acquisitions and investments in new technologies and products[116]. Environmental Compliance and Sustainability - The company has implemented various pollution prevention measures, including clean production and wastewater separation systems, to reduce pollutant emissions[129]. - The company has established emergency response plans for environmental incidents to prevent soil contamination[129]. - The company has optimized its VOCs emission treatment systems, including RTO incineration systems, to ensure compliance with emission standards[130]. - The company’s wastewater treatment systems, including physical and biological treatment, are operating normally and meet discharge standards[130]. - The company has implemented strict compliance with environmental laws and regulations across all operational sites[131]. - The company has invested significantly in environmental protection facilities and technology improvements to comply with environmental regulations, which may increase operational costs if stricter regulations are implemented in the future[86]. Risk Management - The management highlighted potential risks, including supply chain disruptions that could impact production capacity by up to 20%[4]. - The company faces risks related to core competitiveness, operational management, and industry competition due to rapid market changes[79][80][81]. - The company faces risks related to the loss of core technical personnel, which could negatively impact operational performance if competitive compensation and incentives are not maintained[89]. - The ongoing impact of the COVID-19 pandemic continues to create uncertainty in demand due to inflation and geopolitical factors[92]. - The company has encountered risks related to the implementation of fundraising investment projects, which are crucial for enhancing competitiveness but face market uncertainties[93]. Shareholder Commitments and Governance - The company commits to strict compliance with laws and regulations to ensure effective governance and protect minority shareholders' rights[184]. - The company will publicly disclose any failure to fulfill commitments and apologize to shareholders, ensuring accountability for any losses incurred[192]. - The company will not engage in unfair practices that harm its interests or those of its shareholders[187]. - The company will adhere to a profit distribution policy as outlined in its articles of association and future shareholder return plans[188]. - The company publicly apologized to shareholders and investors for not fulfilling commitments during the shareholder meeting and on designated media[196].

Financial Performance - The company's operating revenue for 2021 was CNY 1,252,459,155.24, representing a 23.83% increase compared to CNY 1,011,418,016.27 in 2020[20]. - The net profit attributable to shareholders of the listed company for 2021 was CNY 165,657,630.46, a 21.15% increase from CNY 136,742,721.34 in 2020[20]. - The net profit attributable to shareholders after deducting non-recurring gains and losses increased by 42.45% to CNY 126,168,664.65 in 2021 from CNY 88,571,255.53 in 2020[22]. - The basic earnings per share for 2021 was CNY 1.53, up 24.39% from CNY 1.23 in 2020[21]. - The weighted average return on net assets increased to 6.24% in 2021, up from 5.12% in 2020, an increase of 1.12 percentage points[21]. - The company's cash flow from operating activities decreased by 61.75% to CNY 73,047,039.44 in 2021, compared to CNY 190,983,693.21 in 2020, primarily due to increased inventory purchases[22]. - The total assets of the company at the end of 2021 were CNY 3,862,740,277.63, a 16.94% increase from CNY 3,303,224,167.49 at the end of 2020[20]. - The company's total revenue for the reporting period reached ¥1,252,096,211.03, with a gross margin of 27.55%, an increase of 2.28 percentage points compared to the previous year[114]. - The export revenue amounted to ¥657,689,910.03, showing a year-on-year increase of 41.41%, driven by improved sales channels and recovering demand in international markets[116]. Dividend Distribution - The company plans to distribute a cash dividend of RMB 5.00 per 10 shares, totaling RMB 54,202,776.00, which represents 61.49% of the net profit attributable to shareholders for the year[5]. - As of March 31, 2022, the total share capital of the company is 111,226,800 shares, with 2,821,248 shares held in the repurchase account not participating in the dividend distribution[5]. Corporate Governance - The company has not reported any non-operating fund occupation by controlling shareholders or related parties[7]. - The company has not faced any violations in decision-making procedures for external guarantees[7]. - The company has not disclosed any special arrangements for corporate governance[7]. - The company emphasizes the importance of maintaining a robust governance structure to ensure compliance and effective decision-making[188]. - The company maintains strict independence from its controlling shareholder, with independent operations in business and finance, ensuring no fund misappropriation issues[190]. - The fourth board of directors consists of 9 members, including 3 independent directors, complying with legal requirements for governance[191]. - The fourth supervisory board is composed of 3 members, including 1 employee supervisor, ensuring compliance with legal standards[192]. - The company has established comprehensive management systems, including revised internal control and financial management regulations, enhancing governance[193]. - The company has implemented an information disclosure management system to ensure the accuracy and timeliness of disclosures, in line with regulatory requirements[194]. - There are no significant discrepancies between the company's governance practices and regulatory requirements, ensuring compliance[196]. Research and Development - The company has a strong R&D capability with numerous patents and a mature system for converting research results into products[38]. - The company achieved a total R&D investment of ¥70,763,679.66, representing a 35.71% increase compared to the previous year[66]. - R&D investment accounted for 5.65% of total revenue, an increase of 0.49 percentage points from the previous year[66]. - The company holds a total of 84 patents, including 64 invention patents and 20 utility model patents, reflecting strong R&D capabilities[79]. - The company has developed new production processes for photoinitiators, improving efficiency and reducing environmental impact[62]. - The company is focusing on developing new products and technologies, including UV LED photoinitiators suitable for light-colored inks[62]. - The company has established multiple research centers and received various innovation awards during the reporting period[63]. - The company is focusing on developing new photoinitiators and specialty UV curing materials, although it faces challenges in innovation and market demand fluctuations[87]. Market Position and Strategy - The company is the largest and most comprehensive supplier of photoinitiators in China, with a significant global influence in the UV curing field[37]. - The company is focusing on the core industry of photopolymerization and expanding into the semiconductor sector, aiming for global market development[30]. - The company is actively extending its photopolymerization industry chain and expanding into electronic chemical materials[30]. - The company is committed to enhancing its core competitiveness through independent innovation and technology development[32]. - The company has established a strategic direction centered on the photopolymerization industry and semiconductor industry, aiming for global market expansion[182]. - The company is positioned to benefit from favorable policies related to carbon reduction goals, enhancing the market penetration of its photoinitiator products[143]. Risks and Challenges - The company emphasizes the importance of risk factors in its operations, advising investors to pay attention to potential risks[4]. - The company faces risks from intensified industry competition and potential price declines, despite its stable product quality and customer loyalty[90]. - The company faces exchange rate risks due to a significant portion of its revenue coming from exports, which may be impacted by fluctuations in the RMB to USD exchange rate[91]. - The company is experiencing increased operational management pressure due to rapid growth and expansion, necessitating improvements in its management systems[89]. - The ongoing COVID-19 pandemic continues to pose risks to the company's export business, particularly in countries with poor pandemic control[99]. Investments and Acquisitions - The company acquired 40% of Hongrun Chemical's shares, increasing its stake to 52%, making it a controlling subsidiary[35]. - The company is expanding its semiconductor electronic chemical materials business through acquisitions, including Jinghong Bio and Keli Bio, and introducing strategic investors[34]. - The company plans to acquire 100% equity of Huaihua Taitong, with the acquisition process currently underway[168]. - The company has established a wholly-owned subsidiary, Jiuxing Zhihui, with a registered capital of RMB 10 million for environmental-friendly radiation curing coating projects[169]. - The company acquired 100% equity of Jinghong Biological for RMB 9 million, focusing on electronic chemical materials[169]. Production and Supply Chain - The company has developed new production processes for key products like 1173 and 184, significantly reducing raw material consumption and waste generation[148]. - The company has optimized production lines for its main products, achieving a continuous production process that minimizes hazardous chemical use and waste emissions[158]. - The company has established multiple modern production bases to ensure stable supply of core photoinitiators like 184, TPO, and DETX, enhancing its competitive advantage in the market[82]. - The company is focusing on optimizing its production processes to improve efficiency and reduce costs, while also addressing environmental concerns[184].

Financial Performance - The company's operating revenue for Q1 2022 was CNY 422,988,893.15, representing a year-on-year increase of 35.84%[4] - The net profit attributable to shareholders was CNY 54,775,456.06, reflecting a growth of 43.22% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses increased by 81.57% to CNY 47,604,110.91[4] - Basic and diluted earnings per share were both CNY 0.51, marking a 50.00% increase from the previous year[4] - Net profit for Q1 2022 was ¥60,206,842.13, up 57.5% from ¥38,218,112.15 in Q1 2021[20] - Operating profit for Q1 2022 was ¥73,406,666.63, representing a 59.1% increase compared to ¥46,135,361.21 in Q1 2021[20] - The company reported a total comprehensive income of ¥55,065,668.79 for Q1 2022, compared to ¥37,729,683.16 in Q1 2021[21] Cash Flow - The net cash flow from operating activities reached CNY 37,454,291.96, a significant increase of 1,018.99% year-on-year[4] - In Q1 2022, the cash inflow from operating activities was CNY 392,723,047.60, a 60% increase from CNY 245,289,422.04 in Q1 2021[23] - The net cash flow from operating activities reached CNY 37,454,291.96, compared to CNY 3,347,151.62 in the same period last year, indicating significant improvement[24] - The total cash outflow from investing activities was CNY 709,559,382.35, up from CNY 486,423,258.31 in Q1 2021, resulting in a net cash outflow of CNY 244,329,279.32[24] - The cash inflow from financing activities was CNY 254,143,747.32, compared to CNY 86,205,179.02 in Q1 2021, showing a substantial increase[24] Assets and Liabilities - Total assets at the end of the reporting period were CNY 4,093,240,885.23, up 5.97% from the end of the previous year[5] - The company's current assets totaled RMB 2,214,390,862.45, compared to RMB 2,082,661,951.33 at the end of 2021, indicating an increase of about 6.34%[17] - The total liabilities as of Q1 2022 amounted to ¥1,197,871,927.27, compared to ¥1,024,363,104.63 in Q1 2021, reflecting a 16.9% increase[19] - The company's total liabilities increased to CNY 514,067,191.69 from CNY 485,965,717.47 at the end of 2021[27] - The total equity decreased to CNY 2,576,076,531.22 from CNY 2,582,186,339.85 at the end of 2021[28] Research and Development - Research and development expenses amounted to CNY 21,208,575.74, accounting for 5.01% of operating revenue, a decrease of 0.46 percentage points[5] - Research and development expenses for Q1 2022 totaled ¥21,208,575.74, an increase from ¥17,031,304.12 in Q1 2021[19] - Research and development expenses increased to ¥5,092,449.04 in Q1 2022, up 37.8% from ¥3,696,077.63 in Q1 2021[30] Subsidiaries and Investments - The company’s subsidiary, Hunan Jiuri, contributed to revenue growth following the acquisition of Hongrun Chemical at the end of 2021[9] - The company’s subsidiary, Inner Mongolia Jiuri New Materials Co., Ltd., has commenced production for a new project with an annual capacity of 9,250 tons of photoinitiators and intermediates, which began trial operations on March 15, 2022[15] - The company reported a significant increase in trading financial assets, which rose to RMB 341,343,692.70 from RMB 100,290,000.00, indicating a growth of approximately 240.5%[16] - The company’s long-term equity investments increased slightly to RMB 122,947,518.86 from RMB 122,444,752.95, reflecting a growth of about 0.41%[17] - The company’s investment income for Q1 2022 was ¥4,174,626.19, a significant drop from ¥192,625,232.09 in Q1 2021[30]

2021 年第三季度报告 证券代码：688199 证券简称：久日新材 天津久日新材料股份有限公司 2021 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 一、 主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期 比上年同 | 年初至报告期末 | 年初至报告期 末比上年同期 | | --- | --- | --- | --- | --- | | | | 期增减变 | | 增减变动幅度 | | | | 动幅度(%) | | (%) | | 营业收入 | 265,545,777.90 | 18.12 | 894,241,003.36 | 26.40 | | 归属于上市公司股东的 | 24,487,373.90 | -37.10 | 108,146,877.61 | -5.23 | | 净利润 | ...

Financial Performance - The company reported a significant increase in revenue, achieving a total of 1.5 billion RMB for the first half of 2021, representing a year-on-year growth of 25%[16] - The company's operating revenue increased by 30.26% year-on-year, reaching approximately RMB 628.70 million, driven by strategic price reductions and an expanded market share, with sales of photoinitiators growing by 56.58% compared to the same period last year[24] - Basic earnings per share rose to RMB 0.77, reflecting a 13.24% increase from RMB 0.68 in the same period last year[22] - The net profit attributable to shareholders was approximately RMB 83.66 million, an increase of 11.26% from RMB 75.19 million year-on-year[24] - The gross profit margin for the first half of 2021 was reported at 35%, an increase from 30% in the same period last year[16] - Investment income surged by 361.56% to ¥19,499,392.70, attributed to increased interest income from held financial instruments[100] - Operating costs rose by 31.49% to ¥470,733,404.30, primarily due to increased revenue and the inclusion of transportation costs[102] - Cash flow from operating activities decreased by 27.28% to approximately RMB 69.33 million compared to RMB 95.34 million in the previous year[24] Market Expansion and Strategy - The company provided a positive outlook for the second half of 2021, projecting a revenue growth of 20% to 30% based on current market trends and demand[16] - The company is expanding its market presence in Southeast Asia, targeting a 10% market share in the region by the end of 2022[16] - A strategic acquisition of a local competitor is in progress, which is anticipated to enhance production capacity by 30% and reduce operational costs by 15%[16] - The company plans to continue expanding its product offerings and market presence in the photoinitiator sector, capitalizing on the growing demand for UV curing technology[29] - The company is focusing on expanding its market presence through strategic investments and new product development in the photoinitiator sector[119] Research and Development - The company has invested 100 million RMB in R&D for new technologies aimed at improving product efficiency and sustainability[16] - Research and development expenses accounted for 5.37% of operating revenue, up from 3.59% in the previous year, indicating a focus on innovation[22] - The company achieved a total R&D investment of ¥33,780,917.25, representing a 94.96% increase compared to ¥17,327,487.67 in the previous period[52] - The company holds 61 invention patents and 8 utility model patents, indicating strong innovation capabilities in photoinitiator technology[32] - The company has developed new production processes for light curing agents, significantly reducing the use of hazardous materials and improving environmental safety[49] Environmental Compliance and Sustainability - The company has invested significantly in environmental protection facilities and technology improvements to comply with environmental regulations, which may increase operational costs if stricter laws are implemented in the future[85] - The company has implemented measures to reduce carbon emissions by optimizing production processes and recovering heat from steam waste[146] - Pollution prevention measures include clean production practices and the implementation of rainwater and sewage separation systems[130] - The company has established a comprehensive monitoring program to ensure compliance with environmental regulations and maintain operational transparency[138] - All subsidiaries complied with national and local environmental laws, achieving emissions that meet relevant standards without facing penalties[129] Risks and Challenges - The company faces risks related to market competition, technological changes, and potential fluctuations in tax policies affecting profitability[80][83] - The ongoing COVID-19 pandemic continues to pose risks to the company's export business, particularly in countries with poor pandemic control, potentially affecting demand[93] - The company is at risk of losing core technical personnel due to intensified competition for talent, which could adversely affect its operational performance and long-term development[88] - The company faces potential risks from price fluctuations in the photoinitiator manufacturing industry due to increased competition and external uncertainties caused by the COVID-19 pandemic, leading to pressure on product prices[86] Corporate Governance and Shareholder Relations - The company is committed to adhering to any changes in laws and regulations regarding shareholding and transfer during the holding period[159] - The company will implement a sustainable and stable profit distribution policy, considering the opinions of investors, especially minority shareholders[190] - The company has confirmed that its application documents for the IPO do not contain any false records or significant omissions, taking collective legal responsibility[195] - The company will publicly apologize and compensate investors for any failure to fulfill compensation measures as determined by regulatory authorities[184] - The company commits to minimizing investor losses and will explore solutions to protect investor interests[199]

Financial Performance - The company's operating revenue for 2020 was ¥1,011,418,016.27, a decrease of 24.23% compared to ¥1,334,866,139.24 in 2019[22]. - The net profit attributable to shareholders decreased by 45.01% to ¥136,742,721.34 from ¥248,687,778.77 in the previous year[22]. - The basic earnings per share fell by 56.84% to ¥1.23, down from ¥2.85 in 2019[23]. - The cash flow from operating activities increased by 24.09% to ¥190,983,693.21 compared to ¥153,901,917.19 in 2019[22]. - The company's total assets rose by 11.08% to ¥3,303,224,167.49 at the end of 2020, up from ¥2,973,634,427.79 in 2019[22]. - The net profit attributable to shareholders after deducting non-recurring gains and losses decreased by 63.18% to ¥88,571,255.53[22]. - The weighted average return on equity decreased by 16.48 percentage points to 5.12% from 21.60% in 2019[23]. - The company reported a total of ¥48,171,465.81 in non-recurring gains for 2020, compared to ¥8,138,918.35 in 2019[27]. - The company reported a significant decrease in trading financial assets, with a decline of approximately 55.6% from CNY 1,355,211,447.30 to CNY 601,975,347.03, impacting profits by CNY 30,814,638.32[29]. Research and Development - Research and development expenses accounted for 5.16% of operating revenue, an increase from 4.97% in 2019[23]. - The company applied for 18 new patents during the reporting period, including 13 invention patents and 5 utility model patents[52]. - A total of 52,141,736.74 yuan was invested in research and development, representing a decrease of 21.42% compared to the previous year[55]. - The proportion of total R&D investment to operating income increased to 5.16%, up from 4.97% in the previous year[55]. - The company has developed new products such as macromolecular photoinitiators and low-odor photoinitiators, enhancing its competitive edge in meeting customer needs[46]. - The company’s core technologies are focused on improving process technology to enhance yield and product quality while reducing costs and emissions[49]. - The company has developed a new production process for the TPO light initiator, which simplifies production and reduces the use of hazardous materials[50]. - The company has made significant advancements in the development of low-chlorine light initiators and high-efficiency large molecule TX-type light initiators[51]. Market Position and Strategy - The company is the largest producer of photoinitiators in China, with a comprehensive product range and global influence in the UV curing field[31]. - The company aims to leverage policy support for energy-saving and emission-reduction technologies to increase market penetration of photoinitiators[31]. - The photoinitiator products are widely used in various industries, including wood coatings, plastic coatings, and 3D printing, driven by increasing environmental regulations and market demand[39]. - The company has established a strategic layout in the semiconductor materials field by acquiring Dajing New Materials and Dajing Information, focusing on the industrialization of photoinitiators[84]. - The company is expanding its production capacity with new projects, including an annual production of 9,250 tons of photoinitiators in Inner Mongolia and 87,000 tons of photoinitiators in Dongying[83][84]. - The company emphasizes long-term, stable relationships with high-quality customers, which enhances its competitive edge in the photoinitiator market[75]. - The company is committed to developing new photoinitiators and specialty photopolymer materials, but faces risks related to technological innovation and market demand changes[88]. - The company is actively expanding its market presence through strategic investments and partnerships in the new materials sector[178]. Dividend Policy - The company plans to distribute a cash dividend of RMB 3.50 per 10 shares (including tax) to all shareholders based on the total share capital minus the shares held in the repurchase account[5]. - The total cash dividend amount for 2020 was RMB 79,993,245.34, representing 58.50% of the profits available for distribution[193]. - The cash dividend for the year 2020 accounts for 27.75% of the net profit attributable to shareholders of the listed company in the consolidated financial statements[191]. - The company has maintained a consistent dividend policy over the past three years, with cash dividends of RMB 3.50 in 2020, RMB 10.00 in 2019, and RMB 15.00 in 2018[191]. - The independent directors provided clear consent regarding the dividend distribution proposal, ensuring the protection of minority shareholders' rights[190]. Operational Challenges - The company is experiencing increased operational management challenges due to rapid growth in business scale and employee numbers, necessitating improvements in management systems[89]. - The company is facing risks related to the implementation of fundraising investment projects, particularly concerning land acquisition for the construction of a new facility in Dongying, Shandong[99]. - The construction project for producing 87,000 tons of light-curing materials is currently delayed due to land issues, with only partial work being conducted[100]. - The company is actively monitoring the impact of the COVID-19 pandemic on downstream demand, particularly for its export business[98]. - The company has identified risks of continued decline in gross margin due to competitive pricing strategies adopted in response to market conditions[101]. Corporate Governance - The company has received a standard unqualified audit report from Dahua Certified Public Accountants[5]. - The company emphasizes that the forward-looking statements in the report do not constitute a substantive commitment to investors, highlighting potential investment risks[6]. - The company has confirmed that there are no non-operating fund occupations by controlling shareholders and their related parties[7]. - The company has not violated decision-making procedures for providing guarantees[7]. - The company has reported that all board members can guarantee the authenticity, accuracy, and completeness of the annual report[7]. Production and Supply Chain - The company has established three modern production bases in Shandong, Jiangsu, and Hunan, with plans for three additional bases in Inner Mongolia, Jiangsu, and Shandong[37]. - The company employs a "sales-driven production" model, aligning production plans with customer orders and market trends to ensure product availability[37]. - The company has a centralized procurement model, ensuring efficient management of raw materials based on sales forecasts and production plans[36]. - The company has established modern production bases to ensure stable supply and safety for downstream customers[44]. Environmental and Regulatory Compliance - The company focuses on the research and development of environmentally friendly, energy-efficient, and high-performance photoinitiators, contributing to air pollution prevention and industrial upgrades[150]. - The company has invested heavily in environmental protection measures, but faces potential regulatory changes that could increase operational costs[93]. - The company’s products are essential for achieving national VOCs reduction strategies and carbon neutrality goals[149].

Financial Performance - In 2020, the company's operating revenue was approximately CNY 1.01 billion, a decrease of 24.23% compared to CNY 1.33 billion in 2019[22]. - The net profit attributable to shareholders decreased by 45.01% to CNY 136.74 million from CNY 248.69 million in 2019[24]. - The basic earnings per share fell by 56.84% to CNY 1.23, down from CNY 2.85 in the previous year[23]. - The company reported a net cash flow from operating activities of CNY 190.98 million, an increase of 24.09% compared to CNY 153.90 million in 2019[22]. - The total assets increased by 11.08% to CNY 3.30 billion from CNY 2.97 billion in 2019[22]. - The fourth quarter revenue was CNY 303.97 million, showing a recovery trend compared to earlier quarters[28]. - The company achieved an operating income of ¥1,011,418,016.27, a year-on-year decrease of 24.23%, and a net profit attributable to shareholders of ¥136,742,721.34, down 45.01% year-on-year[78]. - The gross profit margin for the main business was 25.27%, down by 12.17 percentage points compared to the previous year[145]. Research and Development - The company has a strong R&D capability, with numerous patents and a mature system for technology transfer, focusing on environmentally friendly and energy-efficient products[32]. - The company holds 53 invention patents and 8 utility model patents, indicating strong R&D capabilities and innovation in photoinitiator technology[43]. - The total R&D investment amounted to ¥52,141,736.74, a decrease of 21.42% compared to the previous year[57]. - The number of R&D personnel has increased to 192, accounting for 19.12% of the total workforce, up from 16.43% in the previous period[64]. - The company has established a "National Enterprise Technology Center" and a "Tianjin Photoinitiator Technology Engineering Center" to enhance its R&D capabilities[67]. - The company is committed to enhancing its research and development capabilities, particularly in photopolymerization products and electronic chemical materials, to meet diverse customer needs[161]. Market Position and Strategy - The company is the largest and most comprehensive supplier of photoinitiators in China, with a significant global influence in the UV curing field[31]. - The photoinitiator market in China is experiencing stable growth, with significant potential for application expansion compared to developed countries[40]. - The company is transitioning from a conventional photoinitiator manufacturer to a solution provider for UV curing technology, enhancing its market competitiveness[48]. - The company has established long-term, stable relationships with high-quality customers, which enhances its competitive edge in the photoinitiator market[72]. - The company aims to enhance its market position in the light curing industry by diversifying its product line and expanding into new materials, particularly special monomers and resins[159]. Corporate Governance and Compliance - The company has received a standard unqualified audit report from Dahua Certified Public Accountants[5]. - The company does not face any non-operating fund occupation by controlling shareholders or related parties[7]. - The company has not violated decision-making procedures for external guarantees[7]. - The company has a comprehensive decision-making mechanism for profit distribution, ensuring transparency and compliance with regulations to protect minority shareholders' rights[168]. - The company has commitments from major shareholders and management regarding shareholding restrictions and stock price stabilization measures[173]. Risks and Challenges - The company is facing risks related to core competitiveness, as market demand and technological advancements continue to evolve, potentially impacting its market position[85]. - The company is exposed to macroeconomic risks, including exchange rate fluctuations that could affect its export revenues and profits[88]. - The company is experiencing price pressure on its products due to intensified competition and external factors such as the COVID-19 pandemic, leading to a decline in product prices[91]. - The company faces potential risks related to safety production due to the use of hazardous chemicals and processes, which could lead to accidents and regulatory penalties[90]. - Rising labor costs are a concern as the company expands its workforce and increases employee salaries, which may not align with revenue growth[92]. Shareholder Returns - The company plans to distribute a cash dividend of RMB 3.50 per 10 shares to all shareholders, subject to approval at the shareholders' meeting[5]. - The cash dividend proposal for 2020 is to distribute RMB 3.50 per 10 shares (including tax), amounting to a total cash dividend of approximately RMB 37.94 million, which represents 27.75% of the net profit attributable to shareholders[169]. - The company has not proposed a cash profit distribution plan for the reporting period despite having positive distributable profits[172]. - The company repurchased shares amounting to 79,993,245.34 CNY in 2020, representing 58.50% of the cash dividend[172]. Production and Operations - The company operates three modern production bases in Shandong, Jiangsu, and Hunan, with plans for three additional bases to ensure stable product supply[37]. - The production model is based on "sales-driven production," aligning production plans with customer orders and market trends[37]. - The company has developed new production processes for its core products, such as 1173 and 184, which significantly reduce raw material consumption and waste generation, achieving nearly zero wastewater discharge[133]. - The company is expanding its production capacity with 6,200 tons under construction in Inner Mongolia, expected to be completed by December 2021[141].